Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aion Therapeutic Inc (AION.CN)

Aion Therapeutic Inc (AION.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aion Therapeutic Inc 700 West Georgia Street Suite 2200 Vancouver BC V7Y 1K8 CAN

P: 778-480-6455

Description:

Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.

Key Statistics

Overview:

Market Capitalization, $K 6,173
Shares Outstanding, K 411,549
Annual Sales, $ 0 K
Annual Net Income, $ -257 K
Last Quarter Sales, $ 222 K
Last Quarter Net Income, $ -378 K
60-Month Beta 0.16
% of Institutional Shareholders 0.05%

Growth:

1-Year Return 200.00%
3-Year Return -85.71%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm 0.00
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -20.43%
Dividend Payout Ratio 0.00%

AION.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -33.66%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales 13.52
Price/Book 5.98
Book Value/Share 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar